Ajanta Pharma Ltd Share Price

Overview

Ajanta Pharma Ltd share price is currently ₹3,492.99, down by - ₹44.20 (1.25%) from its previous closing price of ₹3,537.19. The share price has gained 4.19% over the past month and gained 31.19% over the past year. The stock's 52-week low and high are ₹2,288.56 and ₹3,771.81, respectively. Ajanta Pharma Ltd has a market capitalisation of ₹ 45,480.00 Cr. The share price was last updated on 25 Aug 2026, 12:41 PM IST.

Ajanta Pharma Ltd

AJANTPHARM

₹0.00

- ₹44.20

1.25%

Healthcare

₹0.00(%)1D

Updated: 25 Aug 2026, 12:41:23 pm IST

Market Data

Open Price

₹3,531.00

Prev. Close

₹3,537.19

₹3,458.27

Day Low

₹3,531.00

Day High

₹2,288.56

52 Week Low

₹3,771.81

52 Week High

HealthcarePharmaceuticals & Drugs

CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

38.58

Sector PE

42.03

PB Ratio

9.64

Sector PB

5.82

EPS

90.54

Dividend Yield

1.00

Today's Volume

64.160 K

5 Day Avg. Volume

67.924 K

PEG Ratio

2.62

Market Cap.

₹ 45,480.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsInterim Dividend of 1600% at ₹32/Share	05-Aug-2026	05-Aug-2026
DividendsInterim Dividend of 1400% at ₹28/Share	10-Nov-2025	10-Nov-2025
DividendsInterim Dividend of 1400% at ₹28/Share	06-Nov-2024	06-Nov-2024

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
Nippon India Small Cap Fund - Growth	16.74 Lac	16.74 Lac no change
Kotak Flexicap Fund - Growth	16.17 Lac	16.17 Lac no change
UTI Flexi Cap Fund - Regular Plan - IDCW	13.50 Lac	13.33 Lac (1.29%)
Kotak Small Cap Fund - Growth	11.45 Lac	11.45 Lac no change
Kotak Large & Midcap Fund - Growth	9.85 Lac	9.85 Lac no change

Show all holdings

About Ajanta Pharma Ltd 👋

Ajanta Pharma Limited is an India-based specialty pharmaceutical company. It provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. It is focused on branded generic businesses across India, Asia, and Africa. It has a wide range of therapeutic segments, such as cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecology, pediatric and general health products. Its business also consists of two verticals: the United States generics and the institutional business in Africa. Its ophthalmology products include Bimat (anti glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic). Its cardiology products include MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex and Vilatin. Its subsidiaries include Ajanta Pharma (Mauritius) Limited, Ajanta Pharma USA Inc., Ajanta Pharma Philippines Inc., and Ajanta Pharma Nigeria Limited.